A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease.
Zecca et al.
Neurology 2006;67:S8-11.
ABSTRACT
| FULL TEXT
Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
Sossi et al.
Brain 2006;129:1050-1058.
ABSTRACT
| FULL TEXT
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model
de la Fuente-Fernandez et al.
Brain 2004;127:888-899.
ABSTRACT
| FULL TEXT
Progression of gait disorder and rigidity and risk of death in older persons
Wilson et al.
Neurology 2002;58:1815-1819.
ABSTRACT
| FULL TEXT
Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease
Ribeiro et al.
Arch Neurol 2002;59:580-586.
ABSTRACT
| FULL TEXT
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour
Zecca et al.
Mol. Pathol. 2001;54:414-418.
ABSTRACT
| FULL TEXT
Preservation of midbrain catecholaminergic neurons in very old human subjects
Kubis et al.
Brain 2000;123:366-373.
ABSTRACT
| FULL TEXT
Critical decline in fine motor hand movements in human aging
Smith et al.
Neurology 1999;53:1458-1458.
ABSTRACT
| FULL TEXT
The substantia nigra of the human brain: I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry
Damier et al.
Brain 1999;122:1421-1436.
ABSTRACT
| FULL TEXT
Is Schizophrenia a Progressive Neurodevelopmental Disorder? Toward a Unitary Pathogenetic Mechanism
Woods
Am. J. Psychiatry 1998;155:1661-1670.
ABSTRACT
| FULL TEXT
Genetic Classification of Primary Neurodegenerative Disease
Hardy and Gwinn-Hardy
Science 1998;282:1075-1079.
ABSTRACT
| FULL TEXT
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
Pohjalainen et al.
Am. J. Psychiatry 1998;155:768-773.
ABSTRACT
| FULL TEXT
Dose-Dependent Effects of the Dopamine D1 Receptor Agonists A77636 or SKF81297 On Spatial Working Memory in Aged Monkeys
Cai and Arnsten
J. Pharmacol. Exp. Ther. 1997;283:183-189.
ABSTRACT
| FULL TEXT
Behavioral and Neurochemical Effects of Intranigral Administration of Glial Cell Line-Derived Neurotrophic Factor on Aged Fischer 344 Rats
Hebert and Gerhardt
J. Pharmacol. Exp. Ther. 1997;282:760-768.
ABSTRACT
| FULL TEXT
Comparison of Neurologic Changes in 'Successfully Aging' Persons vs the Total Aging Population
Odenheimer et al.
Arch Neurol 1994;51:573-580.
ABSTRACT
Effect of Age on D2 Dopamine Receptors in Normal Human Brain Measured by Positron Emission Tomography and 11C-Raclopride
Antonini et al.
Arch Neurol 1993;50:474-480.
ABSTRACT
Reduction of the Substantia Nigra Width and Motor Decline in Aging and Parkinson's Disease
Pujol et al.
Arch Neurol 1992;49:1119-1122.
ABSTRACT
Magnetic Resonance Evaluation of the Midbrain in Parkinson's Disease
Doraiswamy et al.
Arch Neurol 1991;48:360-360.
ABSTRACT
DATATOP: A Multicenter Controlled Clinical Trial in Early Parkinson's Disease: Parkinson Study Group
Arch Neurol 1989;46:1052-1060.
ABSTRACT
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease: A Role for Extranigral Factors?
Morris et al.
Arch Neurol 1989;46:651-657.
ABSTRACT
The Neurologic Implications of Depression in the Elderly
Brumback
J Geriatr Psychiatry Neurol 1988;1:240-241.
Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain
Wong et al.
Science 1984;226:1393-1396.
ABSTRACT
Decreased CSF Concentrations of Homovanillic Acid and {gamma}-Aminobutyric Acid in Alzheimer's Disease: Age- or Disease-Related Modifications?
Bareggi et al.
Arch Neurol 1982;39:709-712.
ABSTRACT
Pathogenesis of Parkinson's Disease
Mann and Yates
Arch Neurol 1982;39:545-549.
ABSTRACT
Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979
Kane and Smith
Arch Gen Psychiatry 1982;39:473-481.
ABSTRACT
Hippocampal aging and adrenocorticoids: quantitative correlations
Landfield et al.
Science 1978;202:1098-1102.
ABSTRACT
